ALBO - Albireo Pharma EPS beats by $0.59 beats on revenue February, 25 2021 08:05 AM Albireo Pharma Inc. Albireo Pharma (ALBO): Q4 GAAP EPS of -$1.30 beats by $0.59.Revenue of $2.72M (-57.7% Y/Y) beats by $0.38M.Press Release For further details see: Albireo Pharma EPS beats by $0.59, beats on revenue